Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 15NIH 3NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Other neoplasm 1Gynecologic 1Breast 1

Conditions

Fatigue 2Depression 2Colorectal Neoplasms 2Colonic Neoplasms 2Anxiety Disorders 2Sleep Wake Disorders 1Rectal Neoplasms 1Pain 1Breast Neoplasms 1Body Weight Changes 1

Interventions

Fluorouracil 74Leucovorin 48Oxaliplatin 44Cisplatin 40Capecitabine 39Gemcitabine 37Radiotherapy 30Irinotecan 28Cetuximab 21Paclitaxel 15Bevacizumab 12Docetaxel 10Taxes 9durvalumab 8dehydroftorafur 8Surgical Procedures, Operative 8Mitomycin 8Specimen Handling 7Platinum 7Folfox protocol 7Carboplatin 7Albumin-Bound Paclitaxel 7130-nm albumin-bound paclitaxel 7S 1 (combination) 6Panitumumab 6Watchful Waiting 5Imatinib Mesylate 5Gene Expression Profiling 5Epirubicin 5tremelimumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Counseling × Gastrointestinal × Clear all
NCT00819208 2026-04-24

CHALLENGE

Canadian Cancer Trials Group

Phase NA Completed
889 enrolled 9 charts
Gastrointestinal

Anxiety Disorders, Colonic Neoplasms, Depression, Fatigue, Sleep Wake Disorders, Colorectal Neoplasms

NCT01453452 2020-01-18

S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors

SWOG Cancer Research Network

Phase NA Completed
50 enrolled
BreastGastrointestinal

Anxiety Disorders, Body Weight Changes, Breast Neoplasms, Colonic Neoplasms, Depression, Fatigue, Pain, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡